Cost Minimization of Using Activated Prothrombin Complex Concentrate Versus Recombinant Activated Factor Vii in Patients With a Nd B Hemophilia in Presence of Inhibitors
Value in Health - United Kingdom
doi 10.1016/j.jval.2016.09.500
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2016
Authors
Publisher
Elsevier BV